4D Molecular Therapeutics...

NASDAQ: FDMT · Real-Time Price · USD
3.44
0.07 (2.08%)
At close: May 01, 2025, 3:59 PM
3.47
1.02%
After-hours: May 01, 2025, 06:55 PM EDT

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics reported an annual revenue of $37K, reflecting a -99.82% growth. For the quarter ending December 31, 2024, 4D Molecular Therapeutics generated $1K in revenue.
Revenue (ttm)
$37K
Revenue Growth
-99.82%
Price / Sales Ratio
8120.72
Revenue / Employee
$163
Employees
227
Market Cap
159.05M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 37K -99.82%
Dec 31, 2023 20.72M +562.29%
Dec 31, 2022 3.13M -82.65%
Dec 31, 2021 18.04M +32.52%
Dec 31, 2020 13.61M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.